Name: Dr. Hyder Ali

Specialty: Rheumatology & Geriatric Medicine (Internal Medicine)

Qualification / Board Certification: MD — Ross University School of Medicine (Class of 2019) | American Board of Internal Medicine Certified | American Board of Internal Medicine — Geriatric Medicine Certified

Affiliation(s): University of Tennessee College of Medicine — Memphis, TN

Location (City/State): Memphis, TN

Languages Spoken: English (additional languages not listed)

Accepting New Patients: Yes

NPI Number: Not publicly available

About the Doctor

Dr. Hyder Ali is a highly trained Internal Medicine physician with dual board certifications in Internal Medicine and Geriatric Medicine, currently completing a Fellowship in Rheumatology at the University of Tennessee College of Medicine in Memphis. He earned his medical degree from Ross University School of Medicine in 2019 and went on to complete his residency in Internal Medicine at Chicago Medical School/Rosalind Franklin University of Medicine & Science from 2021 to 2024. He further pursued a Fellowship in Geriatric Medicine at SUNY Upstate Medical University from 2024 to 2025 before beginning his current Rheumatology Fellowship at the University of Tennessee, which runs through 2027.

Dr. Ali’s unique clinical profile — combining expertise in internal medicine, geriatrics, and rheumatology — positions him as a specialist well-equipped to manage complex, multi-system diseases, particularly in older adults. He has a strong academic foundation, with published research in peer-reviewed journals including the Journal of Clinical Medicine and the American Journal of Therapeutics, covering topics ranging from COVID-19 outcomes to gastrointestinal bleeding management and rheumatologic treatments. His presentation at the SUNY Upstate Beyond The Doctorate Research Day 2025 further reflects his commitment to advancing medical knowledge and patient safety. Dr. Ali is currently accepting new patients.

Key Highlights:

• Dual board-certified in Internal Medicine and Geriatric Medicine
• Currently completing Rheumatology Fellowship at University of Tennessee (2025–2027)
• Published researcher with citations in multiple peer-reviewed journals
• Expertise spanning internal medicine, geriatrics, and rheumatology
• Experience managing complex, multi-system illnesses in adult and elderly patients
• Presented original research at SUNY Upstate Beyond The Doctorate Research Day 2025
• Currently accepting new patients

Education & Training

Medical School:

Ross University School of Medicine — Class of 2019

Residency:

Chicago Medical School / Rosalind Franklin University of Medicine & Science — Internal Medicine, 2021–2024

Fellowship / Additional Training:

• SUNY Upstate Medical University — Geriatric Medicine (Internal Medicine), 2024–2025
• University of Tennessee College of Medicine — Rheumatology, 2025–2027 (Current)

Medical Conditions Treated

Rheumatology:

• Rheumatoid Arthritis
• Lupus (Systemic Lupus Erythematosus)
• Psoriatic Arthritis
• Spondyloarthropathy & Ankylosing Spondylitis
• Gout & Pseudogout
• Sjögren’s Syndrome
• Vasculitis
• Osteoarthritis & Inflammatory Joint Disease
• Polymyalgia Rheumatica
• Fibromyalgia

Geriatric Medicine:

• Dementia & Cognitive Impairment (including medication-induced)
• Falls Prevention & Balance Disorders
• Osteoporosis & Fracture Risk
• Polypharmacy & Medication Management in Elderly Patients
• Frailty & Functional Decline
• Urinary Incontinence
• Delirium & Acute Confusion

Internal Medicine:

• Hypertension & Cardiovascular Risk
• Type 2 Diabetes
• Gastrointestinal Bleeding & GERD
• Respiratory Infections & Pneumonia
• Sepsis & Systemic Infections
• Anemia & Blood Disorders
• COVID-19 & Post-COVID Complications

Medical Procedures Performed

• Comprehensive Internal Medicine & Specialty Evaluations
• Joint Aspiration & Injection (Arthrocentesis)
• Synovial Fluid Analysis
• Rheumatologic Disease Activity Assessment
• Comprehensive Geriatric Assessment (CGA)
• Cognitive Function Testing (MMSE, MoCA)
• Bone Density (DEXA Scan) Ordering & Interpretation
• Medication Review & Polypharmacy Management
• Diagnostic Lab Work & Autoimmune Panel Interpretation (ANA, RF, Anti-CCP)
• Imaging Review (X-ray, MRI, Ultrasound for joints)
• Biologic & DMARD Therapy Management
• Inpatient Medical Evaluation & Acute Care Management
• Specialist Referrals & Multidisciplinary Care Coordination

Services Offered

Dr. Ali’s practice brings together three highly complementary specialties — Internal Medicine, Geriatric Medicine, and Rheumatology — to provide uniquely comprehensive care for adult and elderly patients dealing with complex, overlapping medical conditions. His multidisciplinary training allows him to look beyond a single diagnosis and address the full spectrum of a patient’s health needs in a coordinated, evidence-based manner.

Rheumatology Services:

Dr. Ali provides specialized evaluation and management of autoimmune and inflammatory conditions affecting the joints, muscles, and connective tissues. From diagnosing early rheumatoid arthritis to managing complex cases of lupus or spondyloarthropathy, he develops individualized treatment plans using the latest disease-modifying therapies, biologics, and evidence-based protocols. His published research on methotrexate use in spondyloarthropathy reflects his depth of expertise in this area.

Geriatric Medicine Services:

With dedicated fellowship training in geriatric medicine, Dr. Ali is specially equipped to care for older adults with multiple chronic conditions, cognitive changes, and age-related health challenges. He performs thorough geriatric assessments, reviews complex medication regimens to prevent harmful drug interactions, and develops care plans that prioritize both physical function and quality of life. His original research on solifenacin-induced cognitive impairment highlights his focus on medication safety in elderly patients.

Internal Medicine & Acute Care:

Dr. Ali’s strong internal medicine foundation enables him to manage a wide range of adult illnesses, including infections, gastrointestinal conditions, cardiovascular risk factors, and hospitalized patients requiring acute medical management. His published research on COVID-19 outcomes and gastrointestinal bleeding management further demonstrates his capability in handling critically complex inpatient scenarios.

Services at a Glance:

• Rheumatologic disease diagnosis and long-term management
• Autoimmune and inflammatory condition treatment
• Joint injections and arthrocentesis
• Biologic and DMARD therapy initiation and monitoring
• Comprehensive geriatric assessments
• Cognitive impairment evaluation and management
• Polypharmacy review and medication safety optimization
• Falls risk assessment and prevention
• Osteoporosis evaluation and treatment
• Chronic disease management (diabetes, hypertension, anemia)
• Inpatient acute medical care and hospitalist services
• Multidisciplinary specialist care coordination
• Evidence-based, research-informed treatment planning

Accepted Insurances

Insurance information not publicly listed. Please contact the practice directly to confirm accepted insurance plans:

• Phone: +1 (315) 464-6100

Practice Locations

Location 1 Address: 956 Court Ave, Memphis, TN 38163 Phone: +1 (315) 464-6100

Hospital Affiliations

• University of Tennessee College of Medicine — Memphis, TN (Current Fellowship Affiliation)
• SUNY Upstate Medical University — Syracuse, NY (Geriatric Medicine Fellowship Affiliation)
• Chicago Medical School / Rosalind Franklin University of Medicine & Science — North Chicago, IL (Residency Affiliation)

Publications & Research

PubMed: 4+ Citations

• Association between Body Mass Index and Hospital Outcomes for COVID-19 Patients: A Nationwide Study — Journal of Clinical Medicine, February 2023 (3 citations)
• Clinically Significant Gastrointestinal Bleeding Using Proton Pump Inhibitors or Histamine Type-2 Receptor Antagonists in Patients Intubated for over 48 Hours: A Systematic Review — American Journal of Therapeutics, April 2022 (1 citation)
• The Use of Methotrexate to Treat Peripheral Edema Caused by Spondyloarthropathy — American Journal of Therapeutics, February 2022

Conference Presentations:

• Solifenacin-Induced Cognitive Impairment: A Growing Concern — SUNY Upstate Beyond The Doctorate Research Day 2025, April 9, 2025